AMREP (AXR) has released its Q3 2026 scorecard, with Q2 fiscal 2026 revenue of US$9.4 million and basic EPS of US$0.22, alongside trailing twelve month revenue of US$45.9 million and EPS of US$1.97 as investors weigh the latest move in margins. Over the past six reported quarters, the company has seen quarterly revenue range between US$7.5 million and US$19.1 million, while basic EPS has moved between US$0.13 and US$0.88. This provides a clear data trail on how the business has been converting sales into profit on a per share basis. With net profit margins on a trailing basis higher than last year and the business now operating profitably over the past five years, this set of results keeps the focus firmly on how durable those margins are.

With the latest numbers on the table, the next step is to compare AMREP’s reported results with the prevailing narratives around its growth, profitability and risks to see which stories still hold up and which might need a rethink.

Margins Hold Up With 22.9% Net Return

• On a trailing basis, AMREP reports net profit margin of 22.9%, compared with 19.5% a year earlier, on trailing twelve month revenue of US$45.9 million and net income of US$10.5 million.
• What stands out for a more bullish take is that margin strength coincides with the company being profitable over the past five years, yet earnings are forecast to decline about 1.3% per year. This creates a gap between the solid 22.9% trailing margin and the softer earnings outlook that optimistic investors will need to think through.
  • Supporters can point to five year earnings growth of about 4.4% per year alongside that 22.9% net margin as evidence the business has been able to turn revenue into profit over time.
  • Skeptics can point to the expected 1.3% annual earnings decline despite that margin profile, suggesting current profitability may not translate into similar earnings trends in the forecast period.

Some investors will want to see how this margin story fits into a bigger picture of fair value and long term prospects for the company before leaning too hard in either direction. 📊 Read the what the Community is saying about AMREP.

Earnings Swing Between US$0.13 And US$0.88

• Across the last six reported quarters, basic EPS has ranged from US$0.13 to US$0.88 per share, with recent quarters at US$0.22 and US$0.88, highlighting how lumpy AMREP’s per share profit has been even while the trailing twelve month EPS sits at US$1.97.
• Bears argue that this kind of variability lines up with the forecast of roughly 1.3% annual earnings decline, and the numbers give them material talking points because:
  • Quarterly net income over the period moves between US$0.7 million and US$4.7 million, which means any softer quarter can have a visible impact on EPS, especially for a smaller company.
  • Even with trailing twelve month net income of US$10.5 million, the move down from earlier trailing revenue figures of above US$58.0 million to US$45.9 million suggests the top line has not been on a straight path either.

P/E Of 12.3x Versus Higher Sector Levels

• AMREP’s trailing P/E ratio of 12.3x sits below both the US market at 18.4x and the US Real Estate industry at 29.5x, while the current share price of US$24.43 is above a DCF fair value estimate of about US$20.24.
• What is interesting for a cautious narrative is that the data sends mixed valuation messages, giving both bulls and bears something to point at:
  • Supporters can highlight the 12.3x P/E as looking lower than market and sector averages, and pair that with five year earnings growth of about 4.4% per year as evidence the market might not be fully crediting the company’s history of profitability.
  • Critics focus on the DCF fair value of roughly US$20.24 that sits below the US$24.43 share price and the forecast 6% annual revenue growth alongside 1.3% annual earnings decline, arguing those figures do not clearly point to a bargain.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on AMREP's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If this mix of stronger margins, forecasts and valuation has you on the fence, act sooner rather than later. Weigh the trade off between the concerns and the potential upside yourself, then check out 1 key reward and 1 important warning sign to see how those factors stack up in one place.

See What Else Is Out There

AMREP’s mixed picture of lumpy EPS, softer earnings forecasts and a share price above a DCF fair value estimate gives cautious investors understandable pause.

If that combination of uncertain earnings trends and valuation leaves you hesitant, use our 48 high quality undervalued stocks to quickly zero in on companies where the numbers look more compelling right now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.